FDA workshop on topical antifungals and tretinoid products
Executive Summary
Scheduled for Nov. 16 from 8:30 am to 5 pm in conference room D of the FDA Parklawn Building. Participants, including experts in the field of topical anti-fungal and tretinoid products (Ortho's Retin-A) and FDA officials, will discuss proposed protocols and guidelines for bioequivalence studies for the nonsystemically asborbed products. The agency is also considering inviting reps from the Generic Pharmaceutical Industry Association, the National Association of Pharmaceutical Manufacturers, and the Pharmaceutical Manufacturers Association to provide comments. Notice of the meeting will soon appear in the Federal Register.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.